Antidiabetic Potential of Bululawang Variety Sugarcane (Saccharum officinarum) Syrup: An In-Vivo, α-Amylase Inhibition and In-Silico Evaluation
Indonesian Journal of Chemistry · 03.11.2026 · 26 (6) · 2003
DOI: 10.22146/ijc.115988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indonesian Journal of Chemistry, online erschienen am 03.11.2026. Verfasst von Muh Ade Artasasta und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study evaluated the antidiabetic activity and safety of Bululawang sugarcane (Saccharum officinarum) syrup (BSS) using in vivo and in silico approaches. Antidiabetic activity was assessed in alloxan-induced diabetic mice and an α-amylase inhibition assay, while safety evaluation included physiological observation, kidney function parameters, and blood urea nitrogen (BUN) analysis. Liquid chromatography–mass spectrometry (LC–MS) was used to identify bioactive compounds, followed by molecular docking to investigate their interaction with α-amylase. The results showed a trend toward reduced blood glucose levels at lower doses (10 mg/kg BW) during the 14-day treatment period. Toxicity evaluation revealed no adverse effects on body weight, kidney weight ratio, creatinine, urea, or BUN, which remained within normal physiological ranges. In the α-amylase inhibition assay, BSS exhibited inhibitory activity ranging from 49.139 to 81.798%, with the highest inhibition observed at 100 µg/mL. LC–MS analysis identified several bioactive compounds, including flavonoid glycosides and phenolic compounds. Molecular docking demonstrated that selected compounds exhibited binding affinities toward α-amylase, with 10-desmethoxystreptonigrin showing the strongest interaction (−8.0 kcal/mol), compared to acarbose (−7.7 kcal/mol). These findings suggest potential inhibitory activity against carbohydrate-digesting enzymes.
Zitieren
APA
Artasasta, M. A., Mariana, R. R., Susanti, E., Putri, C. J. W. R., Dewi, P. A. A., & Suciani, N. H. (2026). Antidiabetic Potential of Bululawang Variety Sugarcane (Saccharum officinarum) Syrup: An In-Vivo, α-Amylase Inhibition and In-Silico Evaluation. Indonesian Journal of Chemistry, 26(6), 2003. https://doi.org/10.22146/ijc.115988
Vancouver
Artasasta MA, Mariana RR, Susanti E, Putri CJWR, Dewi PAA, Suciani NH. Antidiabetic Potential of Bululawang Variety Sugarcane (Saccharum officinarum) Syrup: An In-Vivo, α-Amylase Inhibition and In-Silico Evaluation. Indonesian Journal of Chemistry. 2026;26(6):2003. doi:10.22146/ijc.115988
BibTeX
@article{Artasasta2026,
author = {Artasasta, Muh Ade and Mariana, Rina Rifqie and Susanti, Evi and Putri, Cresensia Jessica Wanda Rossyana and Dewi, Putu Ananda Arviana and Suciani, Nurul Hikma},
title = {Antidiabetic Potential of Bululawang Variety Sugarcane (Saccharum officinarum) Syrup: An In-Vivo, α-Amylase Inhibition and In-Silico Evaluation},
journal = {Indonesian Journal of Chemistry},
year = {2026},
volume = {26},
number = {6},
pages = {2003},
doi = {10.22146/ijc.115988}
}
EUVIMED